Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants
NCT07010822Phase 3Recruiting
- Sponsor
- Fighting Infectious Diseases in Emerging Countries
- Start
- Apr 2026
- Primary completion
- Mar 2027
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of nOPV2 in poliomyelitis, sponsored by Fighting Infectious Diseases in Emerging Countries. Started Apr 2026; status: recruiting.
02
Drugs
nOPV2
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT07010822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07010822.